Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Andrologia|October 27, 2020
Structural analysis of the impact of a novel androgen receptor gene mutation in two adult patients with mild androgen insensitivity syndromeMirella Hage, Delphine Drui, Bruno Francou, et al.
Annales D'Endocrinologie|January 16, 2025
Chapter 10: What parathyroid imaging is required for hyperparathyroidism?Benjamin Chevalier, Cécile Ghander, Miriam Ladsous, et al.
Endocrinology, Diabetes & Metabolism Case Reports|June 15, 2016
Dyslipidemia causes overestimation of plasma mitotane measurementsAngelo Paci, Ségolène Hescot, Atmane Seck, et al.
Annals of Surgical Oncology|April 5, 2020
Utility of a Second <sup>99m</sup>Tc-MIBI Scintigraphy Before Reoperation for Patients With Persistent Sporadic Primary Hyperparathyroidism: Results of a Retrospective Multicenter StudySamuel Frey, Clément Couëtte, Christophe Trésallet, et al.
Surgery|September 19, 2019
Self-assessment of voice outcomes after total thyroidectomy using the Voice Handicap Index questionnaire: Results of a prospective multicenter studyFrédéric Borel, Christophe Tresallet, Antoine Hamy, et al.
Langenbeck'S Archives of Surgery|February 20, 2015
Management of thyroid nodules incidentally discovered on MIBI scanning for primary hyperparathyroidismTristan Greilsamer, Claire Blanchard, Niki Christou, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2023
Outcome of adrenocortical carcinoma patients included in early phase clinical trials: Results from the French network ENDOCAN-COMETESégolène Hescot, Véronique Debien, Julien Hadoux, et al.
Annales D'Endocrinologie|April 27, 2025
ENDOCAN-TUTHYREF network consensus recommendations. Refractory medullary thyroid cancerHélène Lasolle, Christine Do Cao, Livia Lamartina, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 28, 2016
Immuno-PET Using Anticarcinoembryonic Antigen Bispecific Antibody and 68Ga-Labeled Peptide in Metastatic Medullary Thyroid Carcinoma: Clinical Optimization of the Pretargeting Parameters in a First-in-Human TrialCaroline Bodet-Milin, Alain Faivre-Chauvet, Thomas Carlier, et al.
Frontiers in Medicine|June 20, 2019
Clinical Results in Medullary Thyroid Carcinoma Suggest High Potential of Pretargeted Immuno-PET for Tumor Imaging and Theranostic ApproachesCaroline Bodet-Milin, Clément Bailly, Yann Touchefeu, et al.
Pageof 9